Overview Financials News + Filings Key Docs Charts Ownership Insiders |
OTIX GLOBAL, INC. (OTIX)
|
Add to portfolio |
|
|
Price: |
$11.01
| | Metrics |
OS: |
27.9
|
M
| |
-105
|
% ROE
|
Market cap: |
$307
|
M
| |
-273
|
% ROIC
|
Net cash:
|
$3.47
|
M
| |
$0.12
|
per share
|
EV:
|
$303
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
($21.6)
|
M
| |
|
|
EBIT
|
($25.2)
|
M
| |
|
|
EPS |
($2.29)
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 | Dec-31-04 | Dec-31-03 | Dec-31-02 |
Revenues | 95.8 | 124.9 | 119.1 | 101.1 | 99.1 | 97.7 | 87.7 | 68.0 |
Revenue growth | -23.3% | 4.9% | 17.7% | 2.0% | 1.5% | 11.4% | 28.9% | 18.8% |
Cost of goods sold | 37.7 | 46.0 | 43.7 | 42.6 | 44.0 | 44.6 | 41.3 | 32.6 |
Gross profit | 58.1 | 78.9 | 75.4 | 58.5 | 55.1 | 53.1 | 46.4 | 35.4 |
Gross margin | 60.7% | 63.2% | 63.3% | 57.9% | 55.6% | 54.4% | 52.9% | 52.1% |
Selling, general and administrative | 59.1 | 70.5 | 64.9 | 50.5 | 51.4 | 43.0 | 36.9 | 28.4 |
Research and development | 6.5 | 8.3 | 8.5 | 7.8 | 7.8 | 9.7 | 9.8 | 8.3 |
EBIT | -38.1 | -2.0 | 1.9 | 0.3 | -4.1 | 0.5 | -0.3 | -1.4 |
EBIT margin | -39.8% | -1.6% | 1.6% | 0.3% | -4.1% | 0.5% | -0.4% | -2.0% |
Pre-tax income | -39.0 | -3.7 | 2.8 | 1.3 | -8.0 | 0.5 | 1.2 | 0.1 |
Income taxes | 0.3 | 0.1 | 1.0 | 0.6 | -1.0 | 0.1 | 0.8 | 0.1 |
Tax rate | | | 35.1% | 45.0% | 12.8% | 14.7% | 68.5% | 67.3% |
Earnings from continuing ops | -39.3 | -3.7 | 1.8 | 0.7 | -6.9 | 0.5 | 0.4 | 0.0 |
Earnings from discontinued ops | -0.1 | -3.9 | -1.1 | -2.3 | -12.7 | 0.0 | | |
Net income | -39.4 | -7.6 | 0.7 | -1.6 | -19.6 | 0.4 | 0.4 | 0.0 |
Net margin | -41.1% | -6.1% | 0.6% | -1.6% | -19.8% | 0.4% | 0.4% | 0.0% |
|
Diluted EPS | ($1.42) | ($0.14) | $0.07 | $0.03 | ($0.32) | $0.02 | $0.02 | $0.00 |
Shares outstanding (diluted) | 27.7 | 27.3 | 27.6 | 23.9 | 21.4 | 22.2 | 21.0 | 20.9 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|